Autopsy report · NCT05894876
A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
Cause of deathOther
“Due to recruitment challenges, the sponsor has decided to terminate the study prematurely.”
Life of this trial
- Registered 11 months before it started.
- Ran for about 11 months before it stopped.
- 43 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Novo Nordisk A/S
- Sponsor type
- Industry
- Conditions
- Idiopathic Short Stature
- Interventions
- No treatment is given
- Participants
- 43
- Sites
- 4
- Countries
- Brazil, Israel, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.